1 completed, 1 terminated, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow ACE inhibitor: new trials by email Literature Review of ACE inhibitor trials Research Report on ACE inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease | Phase 3 | Unknown | Alfa Wassermann Tunisia | 156 | 2019-01-31 | 2019-12-02 |
| Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial Statin, ACE inhibitor, Placebo - Type 1 Diabetes | Phase 3 | Completed | University of Cambridge | 443 | 2009-01-01 | 2018-06-28 |
| PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) Ramipril, Placebo - Type 1 Diabetes | Phase 3 | Terminated | Northwestern University | 65 | 2008-07-01 | 2015-03-17 |
Alfa Wassermann Tunisia (1) · Northwestern University (1) · University of Cambridge (1)
Australia (1) · Canada (1) · Tunisia (1) · United States (1)
David B Dunger, Professor (1) · Imed Frikha, MD (1) · Mark E Molitch, MD (1)
PMID 22416821, PMID 25392936, PMID 29091568, PMID 32108022, PMID 33100044, PMID 38124088, PMID 42056188, PMID 42718842
U01DK071733 (1)